Framework for counseling pregnant women presented. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Framework for counseling pregnant women presented. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Alert. 1995 Apr;10(4):57-8. Unique Identifier : AIDSLINE AIDS/95700228


Abstract: At a recent conference, the Health Resources and Services Administration (HRSA) presented guidelines on how health care providers can implement guidelines for counseling and testing of all pregnant women. At the February, 1995, national meeting in Washington, D.C. on women and HIV, sponsored by the National Institutes of Health, HRSA officials told providers: all settings that provide care to pregnant women should provide voluntary HIV counseling and testing on site; follow-up care for all people with HIV should be provided at counseling and testing sites or by referral; all pregnant women with HIV should be given information on the benefits and potential risks of zidovudine (AZT, Retrovir); AZT should be made available either on site or by referral; follow-up care should be included; caregivers must be sensitive to the high level of distrust and fear that many racial/ethnic-minority people have toward health care providers and experimental protocols; training should be provided for health care workers in HIV counseling and testing, and diagnosis and management of HIV in women. HRSA will provide technical assistance, training materials, and other resources to assist providers with implementation of the counseling and testing guidelines.
Keywords: *Counseling Female Guidelines Health Services Human HIV Infections/*DIAGNOSIS Pregnancy *Pregnancy Complications, Infectious *Women's Health NEWSLETTER ARTICLEKWDcounselingfemaleguidelineshealthserviceshumanhivinfections/KWDdiagnosispregnancyKWDpregnancycomplications,infectiousKWDwomen'shealthnewsletterarticle
951030
M95A0956

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .